Trial Profile
Cerebrospinal Fluid Pharmacokinetics of Daptomycin
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 13 Dec 2023
Price :
$35
*
At a glance
- Drugs Daptomycin (Primary)
- Indications Bacterial infections; Meningitis; Ventriculitis
- Focus Pharmacokinetics
- 18 Feb 2011 Planned End Date changed from 1 Dec 2012 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 25 Jun 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 25 Jun 2010 Actual initiation date (May 2010) added as reported by ClinicalTrials.gov.